SENTI-202, a CAR NK cell therapy, achieved complete remission in AML patients, offering a faster alternative to conventional CAR T-cell therapy. CHS-114, targeting CCR8+ Tregs, showed promising ...

SENTI-202, a CAR NK cell therapy, achieved complete remission in AML patients, offering a faster alternative to traditional CAR T-cell therapy. CHS-114, an anti-CCR8 antibody, showed efficacy in ...

There will definitely be issues because this is so new and it was coded quickly so we couldn't test it out. This is not an official StableAudioOpen repository.